Silence Therapeutics

Contact
silence-therapeutics.com
+49 30 9489 2800

Silence Therapeutics AG

Robert-Rössle-Str. 10
13125 Berlin
Germany
+49 30 9489 2800
silence-therapeutics.com
Contact
Profile News
Contact

About Silence Therapeutics

Silence Therapeutics develops a new generation of medicines by harnessing the body’s natural mechanism of RNA interference, or RNAi, within its cells.

Read more about Silence Therapeutics
Facts about Silence Therapeutics
  • Industry : Biotechnology

News about Silence Therapeutics

Silence Therapeutics

23-Mar-2012 | people

Silence Therapeutics Forms Scientific Advisory Board

Silence Therapeutics plc announced the creation of a Scientific Advisory Board (SAB) with the appointment of two Key Opinion Leaders (KOLs) in the area of ...

Read news
Silence Therapeutics

11-Jan-2012 | business & finance

Silence Therapeutics signs collaboration with miRagen Therapeutics to evaluate delivery of novel microRNA-based therapeutics

Silence Therapeutics plc announced that it has signed an agreement with miRagen Therapeutics, Inc. to assess the delivery potential of Silence’s ...

Read news
Silence Therapeutics

25-Feb-2011 | research and development

Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials

New Patent Broadens Company’s Existing Protection of Optimized RNAi Molecules Including Proprietary AtuRNAi Platform

Read news
Silence Therapeutics

26-Oct-2010 | research and development

Silence Therapeutics Receives Comprehensive Protection for RNAI Structural Modification Technology in Single European Patent

Wide-Ranging New Patent Broadly Covers Novel Aspects of “Zamore Design Rules”

Read news
Silence Therapeutics

14-Jun-2010 | research and development

Silence Therapeutics Announces Issuance of Patent Covering Methods for Enhancing Silencing Activity of RNAi Therapeutics

Patent Covers Structural Modifications Associated with Innovative Zamore 'Design Rules'

Read news
Silence Therapeutics

01-Jun-2010 | research and development

Silence Therapeutics Issued Novel RNAi Patent Covering High-Value Cancer Target in United States

Company Supplements Broad RNAi IP Portfolio and Strengthens Growing Position in Oncology

Read news
Silence Therapeutics

11-May-2010 | people

Silence Therapeutics Appoints New Vice President of Research

Move Bolsters Scientific Team at Company's Research Center in Berlin

Read news
Silence Therapeutics

27-Apr-2010 | business & finance

Silence Therapeutics and AstraZeneca Extend siRNA Delivery Collaboration

Silence Therapeutics plc announced that the Company and AstraZeneca have agreed to a one-year extension of their ongoing small interfering RNA (siRNA) ...

Read news
Show more news about Silence Therapeutics

Here you will find Silence Therapeutics AG